A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.

Leveraging natural language processing to understand financial toxicity in cancer care: A thematic and sentiment analysis of online patient narratives. This is an ASCO Meeting Abstract from the 2025 ...

iCAD, Inc. and Koios Medical have announced a strategic reseller partnership to provide a comprehensive AI suite for breast cancer detection, integrating iCAD's ProFound AI® Breast Health Suite with ...

iCAD partners with RamSoft to integrate AI-powered breast health solutions into radiology platforms, enhancing diagnostic efficiency and patient care. iCAD, Inc. and RamSoft have announced a strategic ...